Procyon Financials
| PCYN Stock | USD 0.24 0.01 4.35% |
Procyon |
Procyon Stock Summary
Procyon competes with Hypera SA, Cumberland Pharmaceuticals, and Nippon Shinyaku. Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US7428063009 |
| Business Address | 164 Douglas Rd, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | procyoncorp.com |
| Phone | 727 447 2998 |
| Currency | USD - US Dollar |
Procyon Key Financial Ratios
Procyon's financial ratios allow both analysts and investors to convert raw data from Procyon's financial statements into concise, actionable information that can be used to evaluate the performance of Procyon over time and compare it to other companies across industries.| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 | |||
| Number Of Employees | 19 | |||
| Beta | -0.35 | |||
| Z Score | 2.2 |
Procyon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Procyon's current stock value. Our valuation model uses many indicators to compare Procyon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procyon competition to find correlations between indicators driving Procyon's intrinsic value. More Info.Procyon is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Procyon by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Procyon's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Procyon Systematic Risk
Procyon's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Procyon volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Procyon correlated with the market. If Beta is less than 0 Procyon generally moves in the opposite direction as compared to the market. If Procyon Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Procyon is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Procyon is generally in the same direction as the market. If Beta > 1 Procyon moves generally in the same direction as, but more than the movement of the benchmark.
Procyon December 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Procyon help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Procyon. We use our internally-developed statistical techniques to arrive at the intrinsic value of Procyon based on widely used predictive technical indicators. In general, we focus on analyzing Procyon Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Procyon's daily price indicators and compare them against related drivers.
| Information Ratio | 8.0E-4 | |||
| Maximum Drawdown | 59.92 |
Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.